SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Biotech Bash - Recs and Wrecks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (91)8/29/1997 8:51:00 PM
From: scaram(o)uche   of 171
 
What problem? Lack of movement in the price of the shares? We know that the hype was minimized while an institution took a big chunk. We have no buyers, as there's no news. Do you think that the lack of price movement reflects a problem? I don't. I just think it reflects a lack of information moving to the public, and healthy scepticism.

If what they said at the annual meeting is true..... that Ciba plans to take two compounds into the clinic and BMY is taking one forward, all within the next year....... the share price "problem" will go away. If you want venture-like returns, you need to take venture-like risk. Again, however, I'd like to know about any problems before the next guy.

Relief of the symptoms is all that SIBI is targeting with the 53 series. To me (naive immunologist), this is a very logical step.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News